Estimates of Relative Annual Pediatric Morbidity/Mortality due to Respiratory Syncytial Virus, Influenza, and Severe Acute Respiratory Syndrome Coronavirus 2 Infections in the United States in Selected Age Groups
| Virus . | Hospitalization Rate/100 000 . | Deaths . |
|---|---|---|
| RSV [16] | 2381 (<1 y of age) | 100–500 (<5 y of age) [19] |
| 111–711 (1 to <5 y of age) | ||
| Influenza [16] | 181 (<1 y of age) | 195 (<21 y of age, 2019–2020 season) |
| 41–86 (1 to <5 y of age) | ||
| SARS-CoV-2 [17, 18] | 25.0 (<5 y of age) | 87 (0–14 y of age as of 28 November 2020) |
| 15.3 (5–17 y of age) |
| Virus . | Hospitalization Rate/100 000 . | Deaths . |
|---|---|---|
| RSV [16] | 2381 (<1 y of age) | 100–500 (<5 y of age) [19] |
| 111–711 (1 to <5 y of age) | ||
| Influenza [16] | 181 (<1 y of age) | 195 (<21 y of age, 2019–2020 season) |
| 41–86 (1 to <5 y of age) | ||
| SARS-CoV-2 [17, 18] | 25.0 (<5 y of age) | 87 (0–14 y of age as of 28 November 2020) |
| 15.3 (5–17 y of age) |
Abbreviations: RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Estimates of Relative Annual Pediatric Morbidity/Mortality due to Respiratory Syncytial Virus, Influenza, and Severe Acute Respiratory Syndrome Coronavirus 2 Infections in the United States in Selected Age Groups
| Virus . | Hospitalization Rate/100 000 . | Deaths . |
|---|---|---|
| RSV [16] | 2381 (<1 y of age) | 100–500 (<5 y of age) [19] |
| 111–711 (1 to <5 y of age) | ||
| Influenza [16] | 181 (<1 y of age) | 195 (<21 y of age, 2019–2020 season) |
| 41–86 (1 to <5 y of age) | ||
| SARS-CoV-2 [17, 18] | 25.0 (<5 y of age) | 87 (0–14 y of age as of 28 November 2020) |
| 15.3 (5–17 y of age) |
| Virus . | Hospitalization Rate/100 000 . | Deaths . |
|---|---|---|
| RSV [16] | 2381 (<1 y of age) | 100–500 (<5 y of age) [19] |
| 111–711 (1 to <5 y of age) | ||
| Influenza [16] | 181 (<1 y of age) | 195 (<21 y of age, 2019–2020 season) |
| 41–86 (1 to <5 y of age) | ||
| SARS-CoV-2 [17, 18] | 25.0 (<5 y of age) | 87 (0–14 y of age as of 28 November 2020) |
| 15.3 (5–17 y of age) |
Abbreviations: RSV, respiratory syncytial virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
